4.7 Review

MicroRNA and cyclooxygenase-2 in breast cancer

Related references

Note: Only part of the references are listed.
Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Oncology

Interplay between cyclooxygenase-2 and microRNAs in cancer

Zexiong Gong et al.

Summary: Tumor-associated inflammation and aberrantly expressed biomarkers play crucial roles in the cancer microenvironment. COX-2, as a prominent inflammatory factor, is highly expressed in tumor cells and contributes to tumor growth, recurrence, and metastasis. Understanding the regulatory role of miRNAs in COX-2 post-transcriptional processes could provide new insights for developing novel COX-2 selective inhibitors based on miRNAs.

MOLECULAR MEDICINE REPORTS (2021)

Review Oncology

Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis

Guillermo Antonio De Paz Linares et al.

Summary: The formation of new blood and lymphatic vessels are essential for cancer progression, especially in breast cancer. Inflammation mediated by COX-2 plays a crucial role in promoting angiogenesis and lymphangiogenesis in breast cancer. Targeting the COX-2/EP4 pathway shows promising potential for breast cancer therapy.

CANCERS (2021)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Review Biochemistry & Molecular Biology

New insights into the functions of Cox-2 in skin and esophageal malignancies

Hyeongsun Moon et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2020)

Article Medicine, Research & Experimental

Long Non-coding RNA LOXL1-AS1 Drives Breast Cancer Invasion and Metastasis by Antagonizing miR-708-5p Expression and Activity

Hui-ting Dong et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2020)

Article Pathology

Detection of COX-2 in liquid biopsy in patients with breast cancer

Camilla Paulla de Souza et al.

JOURNAL OF CLINICAL PATHOLOGY (2020)

Review Medicine, General & Internal

Breast Cancer Treatment A Review

Adrienne G. Waks et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Article Biochemistry & Molecular Biology

miR-4458 regulates cell proliferation and apoptosis through targeting SOCS1 in triple-negative breast cancer

Xiaomeng Liu et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Article Biochemistry & Molecular Biology

MiR-4458 inhibits breast cancer cell growth, migration, and invasiveness by targeting CPSF4

Jianrong Wu et al.

BIOCHEMISTRY AND CELL BIOLOGY (2019)

Review Chemistry, Medicinal

Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018)

Sayyed Mohammad Ismail Mahboubi Rabbani et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2019)

Review Medicine, Research & Experimental

Chemoresistance mechanisms of breast cancer and their countermeasures

Xiwei Ji et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Review Genetics & Heredity

Inflammation-induced DNA damage, mutations and cancer

Jennifer Kay et al.

DNA REPAIR (2019)

Article Multidisciplinary Sciences

JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors

Emily A. Irey et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Toxicology

Beta-ionone-inhibited proliferation of breast cancer cells by inhibited COX-2 activity

Hong-Wei Dong et al.

ARCHIVES OF TOXICOLOGY (2019)

Article Cell Biology

Relevance function of microRNA-708 in the pathogenesis of cancer

Si-nan Sun et al.

CELLULAR SIGNALLING (2019)

Article Medicine, Research & Experimental

A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosis

Xiaoyan Xu et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Review Oncology

Role of miRNAs in immune responses and immunotherapy in cancer

Maria Angelica Cortez et al.

GENES CHROMOSOMES & CANCER (2019)

Review Cell Biology

Cyclooxygenase-2 in cancer: A review

Nasser Hashemi Goradel et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Article Medicine, Research & Experimental

Berberine suppresses growth and metastasis of endometrial cancer cells via miR-101/COX-2

Yu Wang et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Review Biochemistry & Molecular Biology

EP4 as a Therapeutic Target for Aggressive Human Breast Cancer

Mousumi Majumder et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Cell Biology

MicroRNA-101 inhibits angiogenesis via COX-2 in endometrial carcinoma

Ying Liu et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2018)

Article Multidisciplinary Sciences

COX-2 induces oncogenic micro RNA miR655 in human breast cancer

Mousumi Majumder et al.

SCIENTIFIC REPORTS (2018)

Review Endocrinology & Metabolism

Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation

Jacob O'Brien et al.

FRONTIERS IN ENDOCRINOLOGY (2018)

Review Pharmacology & Pharmacy

Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases

Ajaikumar B. Kunnumakkara et al.

BRITISH JOURNAL OF PHARMACOLOGY (2017)

Review Biochemistry & Molecular Biology

Risk Factors and Preventions of Breast Cancer

Yi-Sheng Sun et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)

Article Oncology

EpCAM and COX-2 expression are positively correlated in human breast cancer

Shuhang Gao et al.

MOLECULAR MEDICINE REPORTS (2017)

Review Biotechnology & Applied Microbiology

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

Rajesha Rupaimoole et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

Article Multidisciplinary Sciences

Adrenergic nerves activate an angio-metabolic switch in prostate cancer

Ali H. Zahalka et al.

SCIENCE (2017)

Article Cell Biology

NMI inhibits cancer stem cell traits by downregulating hTERT in breast cancer

Xu Feng et al.

CELL DEATH & DISEASE (2017)

Article Chemistry, Multidisciplinary

MicroRNA-4458 suppresses the proliferation of human lung cancer cells in vitro by directly targeting Lin28B

Chang-hong Liu et al.

ACTA PHARMACOLOGICA SINICA (2017)

Review Neurosciences

Pathophysiological Roles of Cyclooxygenases and Prostaglandins in the Central Nervous System

Tatsurou Yagami et al.

MOLECULAR NEUROBIOLOGY (2016)

Article Biochemistry & Molecular Biology

miR-4458 suppresses glycolysis and lactate production by directly targeting hexokinase2 in colon cancer cells

Yaguang Qin et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Review Oncology

Targeting Inflammation in Cancer Prevention and Therapy

Jelena Todoric et al.

CANCER PREVENTION RESEARCH (2016)

Review Oncology

Targeting microRNAs as key modulators of tumor immune response

Laura Paladini et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)

Review Rheumatology

Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis

Joseph Withrow et al.

ARTHRITIS RESEARCH & THERAPY (2016)

Review Oncology

New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis

Honor J. Hugo et al.

JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2015)

Article Oncology

COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation

Mousumi Majumder et al.

MOLECULAR CANCER RESEARCH (2015)

Review Oncology

Breast Cancer: Major Risk Factors and Recent Developments in Treatment

Wafa Majeed et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)

Article Oncology

MicroRNAome Genome: A Treasure for Cancer Diagnosis and Therapy

Ioana Berindan-Neagoe et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2014)

Article Cell Biology

miR-101 Promotes Breast Cancer Cell Apoptosis by Targeting Janus Kinase 2

Lu Wang et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)

Article Oncology

Cyclooxygenase-2 and the inflammogenesis of breast cancer

Randall E. Harris et al.

WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)

Review Oncology

Stromal cells in tumor microenvironment and breast cancer

Yan Mao et al.

CANCER AND METASTASIS REVIEWS (2013)

Article Oncology

Circulating microRNAs in plasma as early detection markers for breast cancer

Katarina Cuk et al.

INTERNATIONAL JOURNAL OF CANCER (2013)

Review Oncology

miR-221/222: promising biomarkers for breast cancer

Wei-Xian Chen et al.

TUMOR BIOLOGY (2013)

Article Gastroenterology & Hepatology

MicroRNA-143 suppresses gastric cancer cell growth and induces apoptosis by targeting COX-2

Xiao-Li Wu et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2013)

Review Medicine, Research & Experimental

miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy

M. Garofalo et al.

CURRENT MOLECULAR MEDICINE (2012)

Review Biochemistry & Molecular Biology

MicroRNA-mediated breast cancer metastasis: from primary site to distant organs

L. Wang et al.

ONCOGENE (2012)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Biochemistry & Molecular Biology

Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer

G. Mudduluru et al.

ONCOGENE (2011)

Article Biochemistry & Molecular Biology

TRPS1 Targeting by miR-221/222 Promotes the Epithelial-to-Mesenchymal Transition in Breast Cancer

Susanna Stinson et al.

SCIENCE SIGNALING (2011)

Editorial Material Genetics & Heredity

MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer

Maitri Y. Shah et al.

GENOME MEDICINE (2011)

Review Pharmacology & Pharmacy

MicroRNA-21: From Cancer to Cardiovascular Disease

Virginija Jazbutyte et al.

CURRENT DRUG TARGETS (2010)

Review Biotechnology & Applied Microbiology

RNAi-Based Strategies for Cyclooxygenase-2 Inhibition in Cancer

Antonio Strillacci et al.

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)

Review Oncology

Host Factors and Cancer Progression: Biobehavioral Signaling Pathways and Interventions

Susan K. Lutgendorf et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

Article Immunology

miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis

Gang Liu et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2010)

Article Cell Biology

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

Shuomin Zhu et al.

CELL RESEARCH (2008)

Article Biochemistry & Molecular Biology

Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells

Lisa B. Frankel et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Oncology

Vascular endothelial growth factor and its relationship to inflammatory mediators

Laura S. Angelo et al.

CLINICAL CANCER RESEARCH (2007)

Article Biochemistry & Molecular Biology

miR-21-mediated tumor growth

M.-L. Si et al.

ONCOGENE (2007)

Article Anatomy & Morphology

COX-2 expression in invasive breast cancer - Correlation with prognostic parameters and outcome

Aziza Nassar et al.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2007)

Review Oncology

MicroRNA signatures in human cancers

George A. Calin et al.

NATURE REVIEWS CANCER (2006)

Article Medicine, Research & Experimental

The activity of class I, II, III and IV alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in breast cancer

W. Jelski et al.

CLINICAL AND EXPERIMENTAL MEDICINE (2006)

Article Oncology

COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer

AV Timoshenko et al.

BRITISH JOURNAL OF CANCER (2006)

Review Oncology

Oncomirs - microRNAs with a role in cancer

A Esquela-Kerscher et al.

NATURE REVIEWS CANCER (2006)

Article Multidisciplinary Sciences

A microRNA expression signature of human solid tumors defines cancer gene targets

S Volinia et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Medical Laboratory Technology

Activity of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) in the sera of patients with breast cancer

Wojciech Jelski et al.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2006)

Article Oncology

MicroRNA gene expression deregulation in human breast cancer

MV Iorio et al.

CANCER RESEARCH (2005)

Article Biochemistry & Molecular Biology

Human Fip1 is a subunit of CPSF that binds to U-rich RNA elements and stimulates poly(A) polymerase

I Kaufmann et al.

EMBO JOURNAL (2004)

Review Oncology

Cyclooxygenase-2: A potential target in breast cancer

DZ Wang et al.

SEMINARS IN ONCOLOGY (2004)

Article Cardiac & Cardiovascular Systems

Shear stress and VEGF activate IKK via the Flk-1/Cbl/Akt signaling pathway

YX Wang et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)

Review Biochemistry & Molecular Biology

MicroRNAs: Genomics, biogenesis, mechanism, and function

DP Bartel

Article Biotechnology & Applied Microbiology

Expression profiling reveals off-target gene regulation by RNAi

AL Jackson et al.

NATURE BIOTECHNOLOGY (2003)

Review Pharmacology & Pharmacy

Regulation by prostaglandin E2 and histamine of angiogenesis in inflammatory granulation tissue

AK Ghosh

YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2003)

Review Medicine, General & Internal

Alcohol and breast cancer - Review of epidemiologic and experimental evidence and potential mechanisms

KW Singletary et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)

Review Medicine, General & Internal

Inflammation and cancer: back to Virchow?

F Balkwill et al.

LANCET (2001)